Clinical Trial Update: Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating TH-302 in combination with gemcitabine for previously untreated metastatic or locally advanced unresectable pancreatic adenocarcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• TH-302 (evofosfamide) (evofosfamide)

Snippet

Sponsor: ImmunoGenesis | Conditions: Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2017-12-02